Notice of Change to Key Dates for NIDA PAR-21-208, " Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)"
Notice Number:
NOT-DA-21-043

Key Dates

Release Date:

March 31, 2021

Related Announcements

PAR-21-208 - Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice informs applicants of a changes to the Key Dates for Funding Opportunity Announcement (FOA) PAR-21-208, "Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)".  

 
The following Section of PAR-21-208 has been modified to reflect the changed dates:

Currently Reads:

Part 1. Overview Information

Key Dates

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS

Scientific Merit Review

Advisory Council Review

Earliest Start Date

August 10, 2021

August 10, 2021

August 10, 2021

November 2021

January 2022

April 2022

February 15, 2022

February 15, 2022

February 15, 2022

March 2022

May 2022

July 2022

August 10, 2022

August 10, 2022

August 10, 2022

November 2022

January 2023

April 2023

February 15, 2023

February 15, 2023

February 15, 2023

March 2023

May 2023

July 2023

August 10, 2023

August 10, 2023

August 10, 2023

November 2023

January 2024

April 2024

February 15, 2024

February 15, 2024

February 15, 2024

March 2024

May 2024

July 2024


Expiration Date:

February 16, 2024


Modified to Read (changes shown in bold italics):

Part 1. Overview Information

Key Dates

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS

Scientific Merit Review

Advisory Council Review

Earliest Start Date

August 10, 2021

August 10, 2021

August 10, 2021

November 2021

January 2022

April 2022

March 8, 2022

March 8, 2022

March 8, 2022

July 2022

October 2022

January 2022

August 10, 2022

August 10, 2022

August 10, 2022

November 2022

January 2023

April 2023

March 8, 2023

March 8, 2023

March 8, 2023

July 2023

October 2023

January 2023

August 10, 2023

August 10, 2023

August 10, 2023

November 2023

January 2024

April 2024

March 8, 2024

March 8, 2024

March 8, 2024

July 2024

October 2024

January 2024


Expiration Date:

March 9, 2024


All other aspects of this FOA remain the same.  

Inquiries

Please direct all inquiries to:

Amy C. Lossie, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-6092
Email: lossieac@mail.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices